Latest Breaking News On - Munich university medical oncology department - Page 1 : comparemela.com

Moleculin Engages Wolfram C M Dempke, MD, PhD, MBA as its European Chief Medical Officer

/PRNewswire/ Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug.

Nordrhein westfalenUnited statesJenene thomasWalter klempWolframcm dempkeIncyte biosciencesBristol myers squibbMunich university medical oncology departmentGlobal medical affairsKyowa kirin pharmaceutical development ltdMoleculin biotech incPrnewswire moleculin biotech incExpert at novartis oncology global clinical developmentElbland clinic holdingHead of the department haematologyUniversity of halle

Moleculin Biotech (MBRX) Appoints Wolfram C M Dempke as European Chief Medical Officer

Moleculin Biotech (MBRX) Appoints Wolfram C M Dempke as European Chief Medical Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Nordrhein westfalenWalter klempWolframcm dempkeIncyte biosciencesBristol myers squibbElbland clinic holdingMunich university medical oncology departmentGlobal medical affairsKyowa kirin pharmaceutical development ltdMoleculin biotech incHead of the department haematologyUniversity of halleScientific solutionsExpert at novartis oncology global clinical developmentMedical officerVice president